Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 02, 2026
HIVE Digital Technologies (HIVE) Stock: -28.6% Pullback After Major AI Contract and Convertible Notes

HIVE Digital Technologies (HIVE) Stock: -28.6% Pullback After Major AI Contract and Convertible Notes

Key Takeaways

  • HIVE shares declined approximately 28.6% over the past 30 days, retreating from a year-to-date high of $5.34 reached on June 22 to around $3.24 as of early July.
  • The pullback followed a massive rally driven by a landmark $220 million sovereign AI GPU cloud contract with Bell Canada and Cohere, announced on June 18.
  • An upsized $115 million convertible note offering priced on June 25 triggered dilution concerns and accelerated profit-taking among short-term traders.
  • Despite the 30-day decline, HIVE remains up roughly 69% over the full quarter, reflecting a broader transformation from a pure-play Bitcoin miner into an AI and high-performance computing infrastructure company.
  • Analyst sentiment remains broadly positive, with Cantor Fitzgerald, B. Riley, and Rosenblatt all raising price targets following the AI contract announcement.

HIVE Digital Technologies' Evolution Into AI Infrastructure

HIVE Digital Technologies Ltd. operates data centers across Canada, Sweden, and Paraguay. Founded in 2017 as one of the first publicly listed cryptocurrency miners powered by green energy, the company has developed a dual business model. It continues to run a meaningful Bitcoin mining operation while expanding aggressively into high-performance computing and AI cloud services through its subsidiary BUZZ High Performance Computing Inc. The focus on NVIDIA GPU clusters for enterprise AI workloads and sovereign cloud infrastructure has helped reposition HIVE from a crypto-focused name to an emerging player in AI infrastructure, drawing interest from investors tracking compute capacity.

Recent Stock Performance: 30-Day Decline Versus Quarterly Gains

Over the last 30 days, HIVE shares reversed sharply. The stock closed at $4.54 on June 2 and reached a year-to-date peak of $5.34 on June 22 on the back of the large AI infrastructure agreement. By July 2, shares had moved down to approximately $3.24, for a decline of roughly 28.6% from the June 2 close. The move lower gained pace after the company announced the $115 million convertible note offering, which raised questions around dilution and near-term capital structure.

Taking a longer view, the quarterly picture looks different. At the start of April, HIVE traded near $1.92. The stock more than doubled in the weeks that followed amid growing HPC revenue, data center expansion updates, and greater recognition of the AI strategy. Even after the recent pullback, HIVE is still up approximately 69% for the quarter, indicating the 30-day move is largely a correction within an ongoing uptrend. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Catalysts Behind the 30-Day Price Action

The main driver during this period was the June 18 announcement that BUZZ HPC had signed a three-year, $220 million sovereign AI GPU cloud contract with Bell Canada and Cohere Inc. The agreement calls for deployment of 2,304 NVIDIA Grace Blackwell GPUs at Bell’s facility in Merritt, British Columbia, to support a Canadian sovereign AI stack for enterprise and government customers. Shares rose more than 10% in pre-market trading on the news and continued higher, reaching $5.34 on June 22.

At the same time, HIVE reported that the Boden Municipal Council in Sweden had approved acquisition of the 32-megawatt Big Boden data center, a site the company had operated as a tenant since 2018. A letter of intent with a Swedish sovereign technology company for a potential 10-year lease added further positive momentum.

The reversal started in earnest on June 25 when HIVE priced an upsized $115 million zero-coupon exchangeable senior notes offering due 2031, up from an initial $100 million plan. The notes carry an exchange price of approximately $4.83 per share, and the company entered capped call transactions to help limit dilution. Even with those measures, the offering highlighted the capital-intensive nature of the AI expansion and prompted profit-taking after the rapid run higher. Broader weakness in Bitcoin prices in late June also weighed on sentiment given the company’s ongoing crypto mining exposure.

Quarterly Drivers and Analyst Upgrades

The broader quarterly advance reflected a fundamental shift in the company’s narrative. HIVE reported fiscal 2026 revenue of $297.8 million, up 158% year-over-year, including a record $19.5 million from the HPC business. Bitcoin hashrate scaled from 6.5 EH/s to 25.1 EH/s while GPU cloud infrastructure was being built out. The $220 million Bell-Cohere contract provided concrete validation of the HPC strategy and gave analysts clearer revenue visibility, with management targeting contracted HPC annual recurring revenue above $100 million once the GB200 systems are live. Multiple analyst upgrades followed, with price targets moving as high as $8 at B. Riley. The combination of triple-digit revenue growth, tangible AI contracts, and expanding data center assets supported the quarterly performance even as the final weeks brought a sharp correction. I also reviewed recent signals on Tickeron’s AI Daily Buy/Sell Signals to put the price action in context.

Key Factors to Watch Going Forward

Execution on the $220 million Bell-Cohere deployment remains the central variable. The GB200 GPU cluster is expected to enter service between late 2026 and early 2027, so updates on timelines, capital expenditures, or additional customer commitments will draw close attention. Finalization of the Swedish Boden lease and progress on the 100-megawatt Paraguay substation project represent other potential catalysts. On the risk side, Bitcoin price volatility continues to matter because mining still contributes a material share of revenue. The convertible note overhang and any future equity raises under the $300 million at-the-market program could also affect trading. Continued HPC revenue growth, margin improvement, and evidence that infrastructure can translate into long-term recurring cash flows will be important to monitor.

Using AI Tools to Navigate Stocks Like HIVE

In my experience following names that move quickly on contract news and financing announcements, having access to structured data and automated signals can help cut through the noise. I’ve spent time with Tickeron’s AI Trading Bots, which offer a range of strategies across equities and other assets. The platform lets users review historical performance, risk parameters, and timeframes before deciding whether a particular approach fits their objectives. For someone monitoring infrastructure and AI-related stocks, these tools provide one way to stay organized amid volatility without replacing individual research and judgment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: HIVE

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


HIVE in downward trend: price expected to drop as it breaks its higher Bollinger Band on August 20, 2026

HIVE broke above its upper Bollinger Band on August 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 48 similar instances where the stock broke above the upper band. In of the 48 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for HIVE entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HIVE's RSI Indicator exited the oversold zone, of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where HIVE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 20, 2026. You may want to consider a long position or call options on HIVE as a result. In of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for HIVE just turned positive on August 12, 2026. Looking at past instances where HIVE's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HIVE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.966) is normal, around the industry mean (4.401). P/E Ratio (9.174) is within average values for comparable stocks, (21.328). HIVE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.691). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (2.254) is also within normal values, averaging (17.980).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 13.42B. The market cap for tickers in the group ranges from 13 to 928.5B. PKRSF holds the highest valuation in this group at 928.5B. The lowest valued company is BFCH at 13.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was 10%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was -1%. IPST experienced the highest price growth at 339%, while NCPL experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 116%. For the same stocks of the Industry, the average monthly volume growth was 90% and the average quarterly volume growth was 19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 65
P/E Growth Rating: 66
Price Growth Rating: 57
SMR Rating: 76
Profit Risk Rating: 85
Seasonality Score: -2 (-100 ... +100)
View a ticker or compare two or three
HIVE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of cloud networking and enterprise Wi-Fi solution

Industry InvestmentBanksBrokers

Profile
Details
Industry
Computer Communications
Address
7900 Callaghan Road
Phone
N/A
Employees
24
Web
https://www.hivedigitaltechnologies.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.